 
 
EXPLANATION:  CAPITALS INDICATE MAT TER ADDED TO EXISTIN G LAW . 
        [Brackets ] indicate matter deleted from existing law.             *hb0280*      
HOUSE BILL 280  
J5   6lr0036  
  (PRE –FILED)  CF SB 205  
By: Chair, Health Committee (By Request – Departmental – Maryland Insurance 
Administration)  
Requested: September 16, 2025  
Introduced and read first time: January 14, 2026  
Assigned to: Health  
 
A BILL ENTITLED  
 
AN ACT concerning  1 
 
Health Insurance – Mental Health and Substance Use Disorders – Codification 2 
of Federal Requirements  3 
 
FOR the purpose of codifying in State law certain provisions of the Code of Federal 4 
Regulations related to mental health parity and clarifying the authority of the 5 
Maryland Insurance Administration to enforce certain laws; requiring health 6 
insurance carriers to collect and r eport on data related to access to benefits in a 7 
certain manner; requiring health insurance carriers to provide benefits for certain 8 
mental health conditions or substance use disorders under certain circumstances; 9 
requiring health insurance carriers to exp lain differences in access to care under 10 
certain circumstances; requiring the Maryland Insurance Commissioner to review 11 
reports from carriers and provide notice to health insurance carriers of 12 
noncompliance with State law and regulations; and generally rel ating to 13 
requirements for health insurance related to mental health and substance use 14 
disorders.  15 
 
BY repealing and reenacting, with amendments,  16 
 Article – Insurance  17 
 Section 15 –144(a), (c)(1) and (3)(ii), (d), (e), (i)(1), (k), and (l)(1)  18 
 Annotated Code of Maryland  19 
 (2017 Replacement Volume and 2025 Supplement)  20 
 
BY adding to  21 
 Article – Insurance  22 
Section 15 –144(c)(7)  23 
 Annotated Code of Maryland  24 
 (2017 Replacement Volume and 2025 Supplement)  25 
 
BY repealing and reenacting, without amendments,  26 
2 HOUSE BILL 280   
 
  Article – Insurance  1 
Section 15 –144(o)  2 
 Annotated Code of Maryland  3 
 (2017 Replacement Volume and 2025 Supplement)  4 
 
 SECTION 1. BE IT ENACTED BY THE GENERAL ASSEMBLY OF MARYLAND, 5 
That the Laws of Maryland read as follows:  6 
 
Article – Insurance  7 
 
15–144. 8 
 
 (a) (1) In this section the following words have the meanings indicated.  9 
 
  (2) “Carrier” means:  10 
 
   (i) an insurer that holds a certificate of authority in the State and 11 
provides health insurance in the State;  12 
 
   (ii) a health maintenance organization that is licen sed to operate in 13 
the State;  14 
 
   (iii) a nonprofit health service plan that is licensed to operate in the 15 
State; or  16 
 
   (iv) any other person or organization that provides health benefit 17 
plans subject to State insurance regulation.  18 
 
  (3) “CORE TREATMENT ” MEANS A STANDARD TRE ATMENT OR 19 
COURSE OF TREATMENT , THERAPY , SERVICE , OR INTERVENTION INDI CATED BY 20 
GENERALLY RECOGNIZED  INDEPENDENT STANDARD S OF CURRENT MEDICAL  21 
PRACTICE .  22 
 
  [(3)] (4) “Health benefit plan” means:  23 
 
   (i) for a large group or blanket plan, a health benefit plan as defined 24 
in § 15 –1401 of this title;  25 
 
   (ii) for a small group plan, a health benefit plan as defined in §  26 
15–1201 of this title;  27 
 
   (iii) for an individual plan:  28 
 
    1. a health benefit plan as defined in § 15 –1301(l) of this t itle; 29 
or 30 
 
 HOUSE BILL 280  3 
 
     2. an individual health benefit plan as defined in §  1 
15–1301(o) of this title;  2 
 
   (iv) short –term limited duration insurance as defined in § 15 –1301(s) 3 
of this title; or  4 
 
   (v) a student health plan as defined in § 15 –1318(a) of this title.  5 
 
  [(4)] (5) “Medical/surgical benefits” has the meaning stated in 45 C.F.R. 6 
§ 146.136(a) and 29 C.F.R. § 2590.712(a).  7 
 
  [(5)] (6) (I) “Mental health benefits” [has the meaning stated in 45 8 
C.F.R. § 146.136(a) and 29 C.F.R. § 2590.712(a) ] MEANS BENEFITS WITH RESPECT TO 9 
ITEMS OR SERVICES FO R MENTAL HEALTH COND ITIONS THAT ARE DEFI NED UNDER 10 
THE TERMS OF A HEALT H BENEFIT PLAN AND I N ACCORDANCE WITH AP PLICABLE 11 
FEDERAL AND STATE LAW , INCLUDING REQUIREMEN TS THAT : 12 
 
    1. ANY CONDITION DEFINE D UND ER THE TERMS OF THE 13 
HEALTH BENEFIT PLAN AS BEING OR AS NOT B EING A MENTAL HEALTH  CONDITION 14 
BE DEFINED CONSISTEN T WITH GENERALLY REC OGNIZED INDEPENDENT 15 
STANDARDS OF CURRENT  MEDICAL PRACTICE AND  INCLUDE ALL CONDITIO NS, 16 
EXCEPT FOR SUBSTANCE  USE DISORDERS , COV ERED UNDER THE HEALT H BENEFIT 17 
PLAN THAT : 18 
 
    A. FALL UNDER ANY OF TH E DIAGNOSTIC CATEGOR IES 19 
LISTED IN THE MENTAL , BEHAVIORAL , AND NEURODEVELOPMENT AL DISORDERS 20 
CHAPTER , OR EQUIVALENT CHAPTE R, OF THE MOST RECENT V ERSION OF THE 21 
WORLD HEALTH ORGANIZATION ’S INTERNATIONAL CLASSIFICATION OF DISEASES 22 
ADOPTED BY THE FEDER AL DEPARTMENT OF HEALTH AND HUMAN SERVICES ; OR 23 
 
    B. ARE LISTED IN THE MO ST RECENT VERSION OF  THE 24 
AMERICAN PSYCHIATRIC ASSOCIATION ’S DIAGNOSTIC AND STATISTICAL MANUAL 25 
OF MENTAL DISORDERS ; AND  26 
 
    2. TO THE EXTENT GENERA LLY RECOGNIZED 27 
INDEPENDENT STANDARD S OF CURRENT MEDICAL  PRACTICE DO NOT ADDR ESS 28 
WHETHER A CONDITION IS A MENTAL HEALTH C ONDITION , THE CONDITION BE 29 
DEFINED IN ACCORDANC E WITH APPLICABLE FE DERAL AND STATE LAW . 30 
 
   (II) “MENTAL HEALT H BENEFITS ” DOES NOT INCLUDE 31 
MEDICAL /SURGICAL BENEFITS OR  SUBSTANCE USE DISORD ER BENEFITS .  32 
 
  [(6)] (7) “Nonquantitative treatment limitation” means treatment 33 
limitations as defined in 45 C.F.R. § 146.136(a) and 29 C.F.R. § 2590.712(a).  34 
4 HOUSE BILL 280   
 
  
  [(7)] (8) (i) “Parity Act” means the Paul Wellstone and Pete Domenici 1 
Mental Health Parity and Addiction Equity Act of 2008, as amended.  2 
 
   (ii) “Parity Act” includes 45 C.F.R. § 146.136, 29 C.F.R. § 2590.712, 3 
and any other related federal regulations found in the Code of Federal Regulations to 4 
implement or enforce the Paul Wellstone and Pete Domenici Mental Health Parity and 5 
Addiction Equity Act of 2008.  6 
 
  [(8)] (9) “Parity Act classification” means:  7 
 
   (i) inpatient in –network benefits;  8 
 
   (ii) inpatient out–of–network benefits;  9 
 
   (iii) outpatient in –network benefits;  10 
 
   (iv) outpatient out –of–network benefits;  11 
 
   (v) prescription drug benefits; and  12 
 
   (vi) emergency care benefits.  13 
 
  [(9)] (10)  “Product” has the meaning stated in § 15 –1309(a)(3) of this title.  14 
 
  [(10)] (11) (I) “Substance use disorder benefits” [has the meaning stated 15 
in 45 C.F.R. § 146.136(a) and 29 C.F.R. § 2590.712(a) ] MEANS BENEFITS WITH RESPECT 16 
TO ITEMS OR SERVICES  FOR SUBSTANCE USE DI SORDERS THAT ARE DEF INED UNDER 17 
THE TERMS OF  A HEALTH BENEFIT PLA N AND IN ACCORDANCE WITH APPLICABLE 18 
FEDERAL AND STATE LAW , INCLUDING REQUIREMEN TS THAT : 19 
 
    1. ANY DISORDER DEFINED  UNDER THE TERMS OF T HE 20 
HEALTH BENEFIT PLAN AS BEING OR AS NOT B EING A SUBSTANCE USE  DISORDER BE 21 
DEFINED CONSISTENT W ITH GENERALLY RECOGNIZ ED INDEPENDENT STAND ARDS 22 
OF CURRENT MEDICAL P RACTICE AND INCLUDE ALL DISORDERS COVERE D UNDER 23 
THE HEALTH BENEFIT P LAN THAT : 24 
 
    A. FALL UNDER ANY OF TH E DIAGNOSTIC CATEGOR IES 25 
LISTED AS A MENTAL O R BEHAVIORAL DISORDE R DUE TO PSYCHOACTIV E 26 
SUBSTANCE USE , OR EQUIVALENT CATEGO RY, IN THE MENTAL , BEHAVIORAL , AND 27 
NEURODEVELOPMENTAL D ISORDERS CHAPTER , OR EQUIVALENT CHAPTE R, OF THE 28 
MOST RECENT VERSION OF THE WORLD HEALTH ORGANIZATION ’S INTERNATIONAL 29 
CLASSIFICATION OF DISEASES ADOPTED BY T HE FEDERA L DEPARTMENT OF 30 
HEALTH AND HUMAN SERVICES ; OR 31 
 
 HOUSE BILL 280  5 
 
     B. ARE LISTED AS A SUBS TANCE–RELATED AND 1 
ADDICTIVE DISORDER , OR EQUIVALENT CATEGO RY, IN THE MOST RECENT V ERSION 2 
OF THE AMERICAN PSYCHIATRIC ASSOCIATION ’S DIAGNOSTIC AND STATISTICAL 3 
MANUAL OF MENTAL DISORDE RS; AND  4 
 
    2. TO THE EXTENT GENERA LLY RECOGNIZED 5 
INDEPENDENT STANDARD S OF CURRENT MEDICAL  PRACTICE DO NOT ADDR ESS 6 
WHETHER A DISORDER I S A SUBSTANCE USE DI SORDER , THE DISORDER SHALL B E 7 
DEFINED UNDER THE TE RMS OF THE HEALTH BE NEFIT PLAN IN ACCORD ANCE WITH  8 
APPLICABLE FEDERAL A ND STATE LAW . 9 
 
   (II) “SUBSTANCE USE DISORDE R BENEFITS ” DOES NOT 10 
INCLUDE MEDICAL /SURGICAL BENEFITS OR  MENTAL HEALTH BENEFI TS.  11 
 
 (c) (1) Each carrier subject to this section shall:  12 
 
   (i) for each Parity Act classification, identify all nonquantitative 13 
treatment limitations that are applied to mental health benefits, substance use disorder 14 
benefits, and medical/surgical benefits;  15 
 
   (ii) in accordance with the Parity Act AND ANY STATE 16 
REGULATIONS ADOPTED UNDER SUBSECTION (O) OF THIS SECTION , perform and 17 
document comparative analyses of the design and application of all nonquantitative 18 
treatment limitations imposed on mental health benefits and substance use disorder 19 
benefits;  20 
 
   (III) 1. COLLECT AND EVALUATE  RELEVANT DATA IN A 21 
MANNER  REASONABLY DESIGNED TO ASSESS THE IMPACT  OF EACH 22 
NONQUANTITATIVE TREA TMENT LIMITATION ON RELEVANT OUTCOMES RE LATED 23 
TO ACCESS TO MENTAL HEALTH AND SUBSTANCE  USE DISORDER BENEFIT S AND 24 
MEDICAL /SURGICAL BENEFITS ; AND 25 
 
    2. WITH RESPECT TO NONQ UANTITATIVE TR EATMENT 26 
LIMITATIONS RELATED TO NETWORK COMPOSITI ON, COLLECT AND EVALUATE  27 
RELEVANT DATA IN A M ANNER REASONABLY DES IGNED TO ASSESS THE AGGREGATE 28 
IMPACT OF ALL THE NO NQUANTITATIVE TREATM ENT LIMITATIONS ON A CCESS TO 29 
MENTAL HEALTH AND SU BSTANCE USE DISORDER  BEN EFITS AND 30 
MEDICAL /SURGICAL BENEFITS ; 31 
 
   [(iii)] (IV) provide the comparative analysis , INCLUDING THE 32 
EVALUATION OF RELEVA NT DATA , for each nonquantitative treatment limitation 33 
requested by the Commissioner within:  34 
 
    1. 15 working days after a written r equest; or  35 
 
6 HOUSE BILL 280   
 
     2. if adopted by the federal government, less than 15 working 1 
days to align with the federal rule or regulation;  2 
 
   [(iv)] (V) within 30 days after a written request, provide the 3 
comparative analysis for each nonquantitative treatment limitation and related in 4 
operation data analysis, if available and requested by a member in accordance with the 5 
Parity Act disclosure requirements or, for members with individual plans, in accordance 6 
with subsection [(e)(7) ] (E)(8) of this section; and  7 
 
   [(v)] (VI) submit the reports required under paragraph (2) of this 8 
subsection.  9 
 
  (3) The report submitted under paragraph (2) of this subsection shall 10 
include the following information:  11 
 
   (ii) the results of a comparative analysis , INCLUDING THE 12 
EVALUATION OF RELEVA NT DATA , conducted by the carrier on not fewer than five 13 
nonquantitative treatment limitations selected by the Commissioner in accord ance with 14 
paragraph (5) of this subsection; and  15 
 
  (7) IF THE RELEVANT DATA EVALUATED UNDER PARA GRAPH (1)(III) 16 
OF THIS SUBSECTION I NDICATE THAT THE NON QUANTITATIVE TREATME NT 17 
LIMITATION CONTRIBUT ES TO MATERIAL DIFFE RENCES IN ACCESS TO MENTAL 18 
HEALTH AND SUBS TANCE USE DISORDER B ENEFITS AS COMPARED TO 19 
MEDICAL /SURGICAL BENEFITS IN  A PARITY ACT CLASSIFICATION : 20 
 
   (I) THE DIFFERENCES SHAL L BE CONSIDERED A ST RONG 21 
INDICATOR OF NONCOMP LIANCE WITH THE PARITY ACT AND MAY SUBJECT T HE 22 
CARRIER TO THE PROVI SIONS OF SUBSEC TION (K) OF THIS SECTION ; AND 23 
 
   (II) THE CARRIER SHALL SU BMIT TO THE COMMISSIONER 24 
DOCUMENTATION OF REA SONABLE ACTIONS THAT  HAVE BEEN OR ARE BEI NG TAKEN 25 
TO ADDRESS THE MATER IAL DIFFERENCES TO E NSURE COMPLIANCE , IN 26 
OPERATION , WITH THE PARITY ACT WITHIN 15 WORKING DAYS OF A RE QUEST FROM 27 
THE COMMISSIONER FOR THE DOCUMENTATION IN ACC ORDANCE WITH THIS 28 
SECTION . 29 
 
 (d) (1) A carrier subject to this section shall conduct a comparative analysis 30 
for the nonquantitative treatment limitations selected under subsection (c)(5) of this section 31 
as nonquantitative treatment limitations are:  32 
 
   (i) written; and  33 
 
   (ii) in operation.  34 
 
 HOUSE BILL 280  7 
 
   (2) The comparative analysis of the nonquantitative treatment limitations 1 
selected under subsection (c)(5) of this section shall:  2 
 
   (i) demonstrate that the processes, strategies, evidentiary 3 
standards, or other factors used in designing and applying each selected nonquantitative 4 
treatment limitation to mental health benefits and substance use disorder benefits in each 5 
Parity Act classificat ion are comparable to, and are applied no more stringently than, the 6 
processes, strategies, evidentiary standards, or other factors used in designing and 7 
applying each selected nonquantitative treatment limitation to medical/surgical benefits 8 
within the sa me Parity Act classification; [and] 9 
 
   (II) DEMONSTRATE THAT NON E OF THE INFORMATION , 10 
EVIDENCE , SOURCES , OR STANDARDS ON WHIC H A FACTOR OR EVIDEN TIARY 11 
STANDARD IS BASED AR E BIASED OR NOT OBJE CTIVE IN A MANNER TH AT 12 
DISCRIMINATES AGAINS T MENTAL HEALTH OR S UBSTANCE USE DISORDER  13 
BENEFITS AS COMPARED  TO MEDICAL /SURGICAL BENEFITS ; 14 
 
   (III) IN ACCORDANCE WITH T HE PROVISIONS OF PAR AGRAPH (3) 15 
OF THIS SUBSECTION , DEMONSTRATE THAT THE  HEALTH BENEFIT PLAN PROVIDES 16 
MEANINGFUL BENEFITS FOR EACH COVERED MEN TAL HEALTH CO NDITION AND 17 
SUBSTANCE USE DISORD ER IN EVERY PARITY ACT CLASSIFICATION IN  WHICH 18 
MEDICAL /SURGICAL BENEFITS AR E PROVIDED ; AND 19 
 
   [(ii)] (IV) include all information required under the Parity Act AND 20 
ANY STATE REGULATIONS ADO PTED UNDER SUBSECTIO N (O) OF THIS SECTION . 21 
 
  (3) (I) THE BENEFITS PROVIDED  FOR THE MENTAL HEALT H 22 
CONDITION OR SUBSTAN CE USE DISORDER SHAL L BE COMPARED TO THE  BENEFITS 23 
PROVIDED FOR MEDICAL  CONDITIONS AND SURGI CAL PROCEDURES IN EA CH 24 
PARITY ACT CLASSIFICATION TO  DETERMINE WHETHER BE NEFITS AR E 25 
MEANINGFUL .  26 
 
   (II) EXCEPT AS PROVIDED UN DER SUBPARAGRAPH (III) OF THIS 27 
PARAGRAPH , BENEFITS ARE NOT MEA NINGFUL UNLESS COVER AGE IS PROVIDED 28 
FOR A CORE TREATMENT  FOR THE MENTAL HEALT H CONDITION OR SUBST ANCE USE 29 
DISORDER IN EACH CLA SSIFICATION IN WHICH  COVERAGE IS PROVIDED F OR A CORE 30 
TREATMENT FOR ONE OR  MORE MEDICAL CONDITI ONS OR SURGICAL PROC EDURES . 31 
 
   (III) IF THERE IS NO CORE T REATMENT FOR A COVER ED MENTAL 32 
HEALTH CONDITION OR SUBSTANCE USE DISORD ER WITH RESPECT TO A  PARITY 33 
ACT CLASSIFICATION , THE HEAL TH BENEFIT PLAN : 34 
 
8 HOUSE BILL 280   
 
     1. IS NOT REQUIRED TO P ROVIDE BENEFITS FOR A CORE 1 
TREATMENT FOR THE CO VERED MENTAL HEALTH CONDITION OR SUBSTAN CE USE 2 
DISORDER IN THAT PARITY ACT CLASSIFICATION ; AND 3 
 
    2. IS REQUIRED TO PROVI DE BENEFITS FOR THE 4 
COVERED MENTAL HEALT H CONDITION OR SUBSTAN CE USE DISORDER IN E VERY 5 
PARITY ACT CLASSIFICATION IN  WHICH MEDICAL /SURGICAL BENEFITS AR E 6 
PROVIDED . 7 
 
  [(3)] (4) Regardless of whether it was used before the Parity Act was 8 
enacted and as requested by the [Commission ] COMMISSIONER , a carrier shall perform 9 
and provide a comparative analysis for each process, strategy, evidentiary standard, or 10 
other factor used in designing and applying a selected nonquantitative treatment limitation 11 
used during a reporting period.  12 
 
 (e) In providing the  analysis required under subsection (d) of this section, a 13 
carrier shall:  14 
 
  (1) identify the factors used to determine that a nonquantitative treatment 15 
limitation will apply to a benefit, including:  16 
 
   (i) the sources for the factors; AND 17 
 
   [(ii) the f actors that were considered but rejected; and ] 18 
 
   [(iii)] (II) if a factor was given more weight than another, the reason 19 
for the difference in weighting;  20 
 
  (2) identify and define the specific evidentiary standards used to define the 21 
factors and any oth er evidence relied on in designing each nonquantitative treatment 22 
limitation;  23 
 
  (3) include the results of the audits, reviews, and analyses performed on 24 
the nonquantitative treatment limitations identified under subsection (c)(5) of this section 25 
to condu ct the analysis required under subsection (d)(2) of this section for the plans and 26 
products as written;  27 
 
  (4) include the RELEVANT DATA EVALUA TED UNDER SUBSECTION  28 
(C)(1)( III) OF THIS SECTION AND THE results of the audits, reviews, and analyses 29 
performed on the nonquantitative treatment limitations identified under subsection (c)(5) 30 
of this section to conduct the analysis required under subsection (d)(2) of this section for 31 
the plans and products as i n operation;  32 
 
  (5) IF THE RELEVANT DATA  EVALUATED UNDER SUBS ECTION 33 
(C)(1)( III) OF THIS SECTION INDI CATE THAT THE NONQUA NTITATIVE TREATMENT 34 
 HOUSE BILL 280  9 
 
 LIMITATION CONTRIBUT ES TO MATERIAL DIFFE RENCES IN ACCESS TO MENTAL 1 
HEALTH AND SUBSTANCE  USE DISORDER BENEFIT S AS COM PARED TO 2 
MEDICAL /SURGICAL BENEFITS IN  A PARITY ACT CLASSIFICATION , INCLUDE AN 3 
EXPLANATION OF THE D IFFERENCES AND A DIS CUSSION OF THE ACTIO NS THAT 4 
HAVE BEEN OR ARE BEI NG TAKEN BY THE CARR IER TO ADDRESS THE D IFFERENCES ; 5 
 
  [(5)] (6) identify the measures use d to ensure comparable design and 6 
application of nonquantitative treatment limitations that are implemented by the carrier 7 
and any entity delegated by the carrier to manage mental health benefits, substance use 8 
disorder benefits, or medical/surgical benefi ts on behalf of the carrier;  9 
 
  [(6)] (7) disclose the specific findings and conclusions reached by the 10 
carrier that indicate that the health benefit plan is in compliance with this section and the 11 
Parity Act; and  12 
 
  [(7)] (8) identify the process used to comply with the Parity Act disclosure 13 
requirements for mental health benefits, substance use disorder benefits, and 14 
medical/surgical benefits, including:  15 
 
   (i) the criteria for a medical necessity determination;  16 
 
   (ii) reasons for a denial of benefits;  and 17 
 
   (iii) in connection with a member’s request for individual or group 18 
plan information and for purposes of filing an internal coverage or grievance matter and 19 
appeals, plan documents that contain information about processes, strategies, evidentiary 20 
standards, and any other factors used to apply a nonquantitative treatment limitation.  21 
 
 (i) (1) The Commissioner shall:  22 
 
   (i) review each report submitted in accordance with subsections (c), 23 
(d), and (f) of this section to assess each carrier’s complian ce with the Parity Act AND ANY 24 
STATE REGULATIONS ADO PTED UNDER SUBSECTIO N (O) OF THIS SECTION  for each 25 
Parity Act classification;  26 
 
   (ii) notify a carrier in writing of any noncompliance with the Parity 27 
Act OR ANY STATE REGULATIONS ADO PTED UNDER SUBSECTIO N (O) OF THIS 28 
SECTION  before issuing an administrative order; and  29 
 
   (iii) within 90 days after the notice of noncompliance is issued, allow 30 
the carrier to:  31 
 
    1. submit a compliance plan to the Administration to comply 32 
with the Parity Act AND ANY STATE  REGULATIONS ADOPTED UNDER SUBSECTION (O) 33 
OF THIS SECTION ; and  34 
 
10 HOUSE BILL 280   
 
     2. reprocess any claims that were improperly denied, in 1 
whole or in part, because of the noncompliance.  2 
 
 (k) If, as a result of the review required under subsection (i)(1)(i) of this sect ion, 3 
the Commissioner finds that the carrier failed to comply with the Parity Act OR ANY STATE 4 
REGULATIONS ADOPTED UNDER SUBSECTION (O) OF THIS SECTION , and did not 5 
submit a compliance plan to adequately correct the noncompliance, the Commissioner may:  6 
 
  (1) issue an administrative order that requires:  7 
 
   (i) the carrier or an entity delegated by the carrier to cease the 8 
noncompliant conduct or practice; or  9 
 
   (ii) the carrier to provide a payment that has been denied improperly 10 
because of the noncomplia nce; or  11 
 
  (2) impose any other penalty or take any action as authorized:  12 
 
   (i) for an insurer, nonprofit health service plan, or any other person 13 
subject to this section, under this article; or  14 
 
   (ii) for a health maintenance organization, under this article or the 15 
Health – General Article.  16 
 
 (l) (1) A carrier shall have the burden of persuasion in demonstrating that its 17 
design and application of a nonquantitative treatment limitation complies with the Parity 18 
Act AND ANY STATE REGULATIONS ADO PTED UNDER  SUBSECTION (O) OF THIS 19 
SECTION : 20 
 
   (i) in any review conducted by the Commissioner under this section; 21 
or 22 
 
   (ii) in any complaint investigation or market conduct action 23 
undertaken by the Commissioner that involves the application of the Parity Act.  24 
 
 (o) The Commissioner shall, in consultation with interested stakeholders, adopt 25 
regulations to implement this section, including to ensure uniform definitions and 26 
methodology for the reporting requirements established under this section.  27 
 
 SECTION 2. AND BE  IT FURTHER ENACTED, That this Act shall take effect July 28 
1, 2026.  29 
 